Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Salesforce Inc (CRM) vs Koninklijke Philips NV (PHG) Price & Performance

Salesforce IncTrade
Koninklijke Philips NVTrade

Price performance (Past 24H)

Key statistics

Salesforce Inc vs Koninklijke Philips NV — how do they compare? Salesforce Inc trades at $167.23 (market cap $137.23B), while Koninklijke Philips NV trades at $27.11 (market cap $25.47B). The key difference: Salesforce Inc is far larger — about 5.4× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (3.89%). Which is the better fit depends on your goals.

CRMPHG
Market Cap
$137.23B$25.47B
Sector
TechnologyHealth
52-Week High
$270.25$32.91
52-Week Low
$150.12$24.11
Enterprise Value
$167.28B$31.74B
Dividend Yield
1.05%3.89%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Salesforce Inc

Salesforce (CRM) trades at $167.70, down 2.06% amid broader software sector weakness. The stock shows strong fundamentals with consistent earnings beats (Q1 2026 EPS of $3.88 vs $3.13 expected) and robust profitability (77.6% gross margin). Technical indicators are neutral with support at $165 and resistance at $171. Recent AI-driven growth initiatives, including Agentforce reaching $2.9B ARR, position the company for continued expansion despite current market pressures.

CRM presents a compelling long-term opportunity with 76.8% analyst buy ratings and a $235.90 consensus target (40% upside). Risks include sector volatility from AI competition and macroeconomic headwinds, but strong cash flow generation ($13.1B operating cash flow in 2025) and market leadership support the bullish case for patient investors.

Koninklijke Philips NV

PHG trades at $27.34, down 0.22% on the day, with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with net income turning positive to $895M in 2025 after previous losses, supported by strong operating cash flow of $1.17B. Recent FDA clearances for AI-powered medical devices and strategic healthcare partnerships demonstrate innovation momentum.

The stock presents a mixed outlook with 41% analyst buy ratings but bearish technical indicators. Key opportunities include AI healthcare adoption and margin expansion, while risks involve competitive pressures and debt levels. Valuation appears reasonable with P/E of 24.01 and P/S of 1.31, but requires monitoring of execution against growth expectations.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Salesforce Inc

Salesforce Inc provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.

Read more on CRM

About Koninklijke Philips NV

Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.

Read more on PHG